Observational analysis finds abnormal dna methylation patterns in cell-free DNA for pan-cancer detection, suggesting a promising non-invasive biomarker.
Aberrant DNA methylation is a hallmark of cancer, and plasma cell-free DNA (cfDNA) containing these abnormal methylation patterns has emerged as a promising non-invasive biomarker for pan-cancer detection. However, intrinsic...
No takes yet. Share an insight, caveat, or question.
Dube et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: